{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:51:16Z","timestamp":1792461076167,"version":"4.5.0"},"reference-count":84,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council for Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Psoriasis is a chronic autoimmune disease affecting millions worldwide. This condition is characterized by scaly, red patches of skin that can be painful, itchy, and disfiguring. This non-contagious illness forms plaques and accelerates the dermal cell\u2019s life cycle. This review provides a comprehensive overview of the current knowledge on psoriasis, covering its definition, prevalence, causes, pathogenesis, clinical features, diagnosis, and treatment options. The psychosocial impact of psoriasis on patients and their coping mechanisms is also explored. Biologic agents, which target specific cytokines involved in psoriasis pathogenesis, have revolutionized psoriasis treatment and have significantly improved patient outcomes. However, effective and safe treatments for moderate to severe psoriasis are still needed. Future research directions include the development of biomarkers for predicting disease severity and treatment response, investigating new therapeutic targets like the microbiome and epigenetics, and leveraging advancements in technology and genomics for deeper insights into psoriasis pathogenesis and treatment. This study summarizes the key aspects of psoriasis, including its epidemiology, pathophysiology, clinical traits, disease burden, and management. However, further research is needed to improve treatment outcomes and enhance the quality of life for patients affected by this complex condition.<\/jats:p>","DOI":"10.7717\/peerj.19325","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:20:33Z","timestamp":1745914833000},"page":"e19325","source":"Crossref","is-referenced-by-count":20,"title":["Advancements in understanding and treating psoriasis: a comprehensive review of pathophysiology, diagnosis, and therapeutic approaches"],"prefix":"10.7717","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0535-0324","authenticated-orcid":true,"given":"Sai","family":"Chakith M. R.","sequence":"first","affiliation":[{"name":"Department of Pharmacology, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Pradeep","sequence":"additional","affiliation":[{"name":"Department of Radio Diagnosis, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Gangadhar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaithra","family":"Maheshwari N.","sequence":"additional","affiliation":[{"name":"Department of Microbiology, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaib","family":"Pasha","sequence":"additional","affiliation":[{"name":"Department of Biotechnology & Bioinformatics, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Prasad","family":"Kollur","sequence":"additional","affiliation":[{"name":"School of Physical Sciences, Amrita Vishwa Vidyapeetham, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagashree","family":"S.","sequence":"additional","affiliation":[{"name":"Department of Information Science and Engineering, JSS Academy of Technical Education, Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1886-139X","authenticated-orcid":true,"given":"Chandan","family":"Shivamallu","sequence":"additional","affiliation":[{"name":"Department of Biotechnology & Bioinformatics, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Allur Mallanna","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"4","key":"10.7717\/peerj.19325\/ref-1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.7717\/peerj.19325\/ref-2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatology"},{"issue":"19","key":"10.7717\/peerj.19325\/ref-3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.7717\/peerj.19325\/ref-4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jaad.2016.10.017","article-title":"From the medical board of the national psoriasis foundation: treatment targets for plaque psoriasis","volume":"76","author":"Armstrong","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.7717\/peerj.19325\/ref-5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/0378-6323.115506","article-title":"Comorbidities in psoriasis","volume":"79","author":"Aurangabadkar","year":"2013","journal-title":"Indian Journal of Dermatology, Venereology, and Leprology"},{"issue":"2","key":"10.7717\/peerj.19325\/ref-6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"issue":"12","key":"10.7717\/peerj.19325\/ref-7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1365-4632.2010.04570.x","article-title":"The role of drugs in the induction and\/or exacerbation of psoriasis","volume":"49","author":"Basavaraj","year":"2010","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7525-4-35","article-title":"Quality of life in patients with psoriasis","volume":"4","author":"Bhosle","year":"2006","journal-title":"Health and Quality of Life Outcomes"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/bjd.15390","article-title":"The role of the skin microbiome in atopic dermatitis: a systematic review","volume":"177","author":"Bjerre","year":"2017","journal-title":"British Journal of Dermatology"},{"key":"10.7717\/peerj.19325\/ref-10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/PTT.S328447","article-title":"Assessing and improving psychological well-being in psoriasis: considerations for the clinician","volume":"12","author":"Blackstone","year":"2022","journal-title":"Psoriasis: Targets and Therapy"},{"issue":"9997","key":"10.7717\/peerj.19325\/ref-11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"The Lancet"},{"issue":"4","key":"10.7717\/peerj.19325\/ref-12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/ar2457","article-title":"The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis","volume":"10","author":"Brown","year":"2008","journal-title":"Arthritis Research & Therapy"},{"key":"10.7717\/peerj.19325\/ref-13","doi-asserted-by":"publisher","first-page":"880201","DOI":"10.3389\/fimmu.2022.880201","article-title":"Epidemiology of psoriasis and comorbid diseases: a narrative review","volume":"13","author":"Bu","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jphs.2020.06.003","article-title":"Predictive role of vitamin A serum concentration in psoriatic patients treated with IL-17 inhibitors to prevent skin and systemic fungal infections","volume":"144","author":"Campione","year":"2020","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4","key":"10.7717\/peerj.19325\/ref-15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000508165","article-title":"Dermoscopic features of nail psoriasis: an observational, analytical study","volume":"6","author":"Chauhan","year":"2020","journal-title":"Skin Appendage Disorders"},{"key":"10.7717\/peerj.19325\/ref-16","doi-asserted-by":"publisher","first-page":"589726","DOI":"10.3389\/fmicb.2020.589726","article-title":"Skin and gut microbiome in psoriasis: gaining insight into the pathophysiology of it and finding novel therapeutic strategies","volume":"11","author":"Chen","year":"2020","journal-title":"Frontiers in Microbiology"},{"issue":"3","key":"10.7717\/peerj.19325\/ref-17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/ijd.14671","article-title":"Biological therapy for pustular psoriasis: a systematic review","volume":"59","author":"Falto-Aizpurua","year":"2020","journal-title":"International Journal of Dermatology"},{"key":"10.7717\/peerj.19325\/ref-18","first-page":"9","article-title":"Psoriasis: comorbidities and associations","volume":"146","author":"Farley","year":"2011","journal-title":"Giornale Italiano Di Dermatologia E Venereologia"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1159\/000448918","article-title":"Phototherapy with narrow-band UVB in adult guttate psoriasis: results and patient assessment","volume":"232","author":"Fern\u00e1ndez-Guarino","year":"2016","journal-title":"Dermatology"},{"key":"10.7717\/peerj.19325\/ref-20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1046\/j.1365-2133.1997.19472062.x","article-title":"Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress","volume":"137","author":"Fortune","year":"1997","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.7717\/peerj.19325\/ref-21","doi-asserted-by":"publisher","first-page":"573.e1\u2013573.e13","DOI":"10.1016\/j.jaad.2005.03.046","article-title":"Epidemiology of psoriatic arthritis in the population of the United States","volume":"53","author":"Gelfand","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"10.7717\/peerj.19325\/ref-22","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3390\/ijms18112427","article-title":"Treatment approaches to moderate to severe psoriasis","volume":"18","author":"Gisondi","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clinics in Dermatology"},{"key":"10.7717\/peerj.19325\/ref-24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13555-020-00475-8","article-title":"Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations","volume":"11","author":"Gisondi","year":"2021","journal-title":"Dermatology and Therapy (Heidelberg)"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case? Control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"10148","key":"10.7717\/peerj.19325\/ref-26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"The Lancet"},{"issue":"3","key":"10.7717\/peerj.19325\/ref-27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.7717\/peerj.19325\/ref-28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"41","key":"10.7717\/peerj.19325\/ref-29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1073\/pnas.1606996113","article-title":"Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function","volume":"113","author":"Ippagunta","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-30","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"The American Journal of Human Genetics"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-31","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/ijms21051690","article-title":"Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review","volume":"21","author":"Kamata","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.7717\/peerj.19325\/ref-32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1346-8138.1997.tb02779.x","article-title":"Natural history of psoriasis: a study from the Indian subcontinent","volume":"24","author":"Kaur","year":"1997","journal-title":"The Journal of Dermatology"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: which therapy for which patient\u2014psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.7717\/peerj.19325\/ref-34","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim","year":"2017","journal-title":"Canadian Family Physician"},{"issue":"6","key":"10.7717\/peerj.19325\/ref-35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","volume":"58","author":"Kimball","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.7717\/peerj.19325\/ref-36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2340\/00015555-1148","article-title":"Teledermatological monitoring of psoriasis patients on biologic therapy","volume":"91","author":"Koller","year":"2011","journal-title":"Acta Dermato Venereologica"},{"key":"10.7717\/peerj.19325\/ref-37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40257-015-0169-x","article-title":"US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey","volume":"17","author":"Lebwohl","year":"2016","journal-title":"American Journal of Clinical Dermatology"},{"issue":"7","key":"10.7717\/peerj.19325\/ref-38","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1007\/s12325-022-02155-9","article-title":"Real-world biologic adherence, persistence, and monotherapy comparisons in US patients with psoriasis: results from IBM MarketScan\u00ae databases","volume":"39","author":"Leonardi","year":"2020","journal-title":"Advances in Therapy"},{"issue":"2","key":"10.7717\/peerj.19325\/ref-39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.23736\/S0391-1977.20.03190-9","article-title":"Vitamin D and psoriasis: an update for dermatologists and nutritionists","volume":"45","author":"Megna","year":"2020","journal-title":"Minerva Endocrinologica"},{"issue":"4","key":"10.7717\/peerj.19325\/ref-40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies","volume":"60","author":"Menter","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaad.2009.08.026","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy","volume":"62","author":"Menter","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.7717\/peerj.19325\/ref-42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/CCID","article-title":"Inverse psoriasis: from diagnosis to current treatment options","volume":"12","author":"Micali","year":"2019","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"issue":"12","key":"10.7717\/peerj.19325\/ref-43","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/jdv.13354","article-title":"European S3-Guidelines on the systemic treatment of psoriasis vulgaris\u2014update 2015\u2014short version\u2014EDF in cooperation with EADV and IPC","volume":"29","author":"Nast","year":"2015","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"11","key":"10.7717\/peerj.19325\/ref-44","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.7717\/peerj.19325\/ref-46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/1346-8138.16733","article-title":"Clinical characteristics of patients with psoriasis with family history: a multicenter observational study","volume":"50","author":"Ohata","year":"2023","journal-title":"The Journal of Dermatology"},{"issue":"2","key":"10.7717\/peerj.19325\/ref-47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5114\/ada.2020.94834","article-title":"Teledermatology: idea, benefits and risks of modern age\u2014a systematic review based on melanoma","volume":"37","author":"Pala","year":"2020","journal-title":"Post\u0119py Dermatologii i Alergologii"},{"key":"10.7717\/peerj.19325\/ref-48","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9","key":"10.7717\/peerj.19325\/ref-49","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/jid.2015.87","article-title":"Identification and management of psoriasis associated ComorbidiTy (IMPACT) project team, psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink","volume":"135","author":"Parisi","year":"2015","journal-title":"The Journal of Investigative Dermatology"},{"issue":"2","key":"10.7717\/peerj.19325\/ref-50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"key":"10.7717\/peerj.19325\/ref-51","doi-asserted-by":"publisher","first-page":"741037","DOI":"10.3389\/fchem.2021.741037","article-title":"Synthesis, computational pharmacokinetics report, conceptual DFT-based calculations and anti-acetylcholinesterase activity of hydroxyapatite nanoparticles derived From Acorus Calamus plant extract","volume":"9","author":"Pradeep","year":"2021","journal-title":"Frontiers in Chemistry"},{"issue":"20","key":"10.7717\/peerj.19325\/ref-52","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1080\/07391102.2022.2158943","article-title":"Molecular insights into the in silico discovery of corilagin from Terminalia chebula as a potential dual inhibitor of SARS-CoV-2 structural proteins","volume":"41","author":"Pradeep","year":"2022a","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"10.7717\/peerj.19325\/ref-53","doi-asserted-by":"publisher","first-page":"1044248","DOI":"10.3389\/fphar.2022.1044248","article-title":"Anticholinesterase activity of Areca Catechu: in vitro and in silico green synthesis approach in search for therapeutic agents against Alzheimer\u2019s disease","volume":"13","author":"Pradeep","year":"2022b","journal-title":"Frontiers in Pharmacology"},{"key":"10.7717\/peerj.19325\/ref-54","doi-asserted-by":"publisher","first-page":"1549186","DOI":"10.3389\/fchem.2025.1549186","article-title":"Exploring shared therapeutic targets for Alzheimer\u2019s disease and glioblastoma using network pharmacology and protein-protein interaction approach","volume":"13","author":"Pradeep","year":"2025","journal-title":"Frontiers in Chemistry"},{"issue":"10","key":"10.7717\/peerj.19325\/ref-55","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3390\/jcm11102801","article-title":"Sharing patient and clinician experiences of moderate-to-severe psoriasis: a nationwide Italian survey and expert opinion to explore barriers impacting upon patient wellbeing","volume":"11","author":"Prignano","year":"2022","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.7717\/peerj.19325\/ref-56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/1744666X.2017.1292137","article-title":"The role of IL 23 in the treatment of psoriasis","volume":"13","author":"Puig","year":"2017","journal-title":"Expert Review of Clinical Immunology"},{"issue":"11","key":"10.7717\/peerj.19325\/ref-57","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/11591580-000000000-00000","article-title":"The burden of moderate to severe psoriasis: an overview","volume":"30","author":"Raho","year":"2012","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.7717\/peerj.19325\/ref-58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.7717\/peerj.19325\/ref-59","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.7717\/peerj.19325\/ref-60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.26574\/maedica.2019.14.3.287","article-title":"Psychological stress and depression in psoriasis patients\u2014a dermatologist\u2019s perspective","volume":"14","author":"Rigas","year":"2019","journal-title":"Maedica (Bucharest, Romania 2015)"},{"issue":"10","key":"10.7717\/peerj.19325\/ref-61","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.7717\/peerj.19325\/ref-62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jaad.2011.01.032","article-title":"Treatment of pustular psoriasis: from the medical board of the national psoriasis foundation","volume":"67","author":"Robinson","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.7717\/peerj.19325\/ref-63","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaad.2009.05.048","article-title":"Treatment of erythrodermic psoriasis: from the medical board of the national psoriasis foundation","volume":"62","author":"Rosenbach","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaad.2013.08.042","article-title":"Research gaps in psoriasis: opportunities for future studies","volume":"150","author":"Ryan","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-65","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.07071.x","article-title":"Measuring quality of life of patients with different clinical types of psoriasis using the SF-36","volume":"20","author":"Sampogna","year":"2006","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.7717\/peerj.19325\/ref-66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s40257-014-0064-x","article-title":"Systemic therapies for psoriasis: an evidence-based update","volume":"150","author":"Sandoval","year":"2014","journal-title":"American Journal of Clinical Dermatology"},{"issue":"S2","key":"10.7717\/peerj.19325\/ref-67","first-page":"2519","article-title":"Evaluation of anti-inflammatory activity of cilnidipine in albino Wistar rats","volume":"12","author":"Satish","year":"2023","journal-title":"European Chemical Bulletin"},{"key":"10.7717\/peerj.19325\/ref-68","first-page":"31","article-title":"In-silico evaluation of anti-acne property of Syzygium (S.) aromaticum","volume":"9","author":"Shivalingaiah","year":"2022a","journal-title":"International Journal of Food Sciences and Nutrition"},{"key":"10.7717\/peerj.19325\/ref-69","first-page":"37","article-title":"Computational approach in search of therapeutic for Colorectal Cancer","volume":"9","author":"Shivalingaiah","year":"2022b","journal-title":"International Journal of Food Sciences and Nutrition"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-70","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jaad.2019.10.050","article-title":"Psoriasis and the risk of migraines in the United States","volume":"156","author":"Steuer","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaad.2016.03.026","article-title":"Clinical meaningfulness of complete skin clearance in psoriasis","volume":"75","author":"Strober","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"10.7717\/peerj.19325\/ref-72","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/jdv.13248","article-title":"A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus","volume":"29","author":"Strohal","year":"2015","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.7717\/peerj.19325\/ref-73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/PTT","article-title":"Psoriasis and alcohol","volume":"9","author":"Svanstr\u00f6m","year":"2019","journal-title":"Psoriasis: Targets and Therapy"},{"issue":"3","key":"10.7717\/peerj.19325\/ref-74","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.7717\/peerj.19325\/ref-75","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/11597000-000000000-00000","article-title":"Nail psoriasis: a review","volume":"13","author":"Tan","year":"2012","journal-title":"American Journal of Clinical Dermatology"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ced.14314","article-title":"Management of nail psoriasis","volume":"46","author":"Thomas","year":"2021","journal-title":"Clinical and Experimental Dermatology"},{"issue":"12","key":"10.7717\/peerj.19325\/ref-77","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nature Genetics"},{"issue":"5","key":"10.7717\/peerj.19325\/ref-78","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/A:1008944108101","article-title":"Coping and quality of life in patients with psoriasis","volume":"8","author":"Wahl","year":"1999","journal-title":"Quality of Life Research"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-79","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jaad.2020.01.065","article-title":"Clinical effectiveness and cost-effectiveness of teledermatology: where are we now, and what are the barriers to adoption?","volume":"83","author":"Wang","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.7717\/peerj.19325\/ref-80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13223-021-00532-7","article-title":"Prevalence of adult eczema, hay fever, and asthma, and associated risk factors: a population-based study in the northern Grassland of China","volume":"17","author":"Wang","year":"2021","journal-title":"Allergy, Asthma & Clinical Immunology"},{"issue":"11","key":"10.7717\/peerj.19325\/ref-81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11883-021-00963-y","article-title":"Psoriasis and cardiovascular disease: novel mechanisms and evolving therapeutics","volume":"29","author":"Weber","year":"2021","journal-title":"Current Atherosclerosis Reports"},{"key":"10.7717\/peerj.19325\/ref-82","article-title":"Global report on psoriasis","author":"World Health Organization","year":"2016"},{"key":"10.7717\/peerj.19325\/ref-83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.15570\/actaapa.2023.3","article-title":"Dermoscopy: the ultimate tool for diagnosis of nail psoriasis? A review of the diagnostic utility of dermoscopy in nail psoriasis","volume":"32","author":"Yorulmaz","year":"2023","journal-title":"Acta Dermatovenerologica Alpina Pannonica et Adriatica"},{"issue":"1","key":"10.7717\/peerj.19325\/ref-84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death & Disease"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/19325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19325.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19325.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:20:39Z","timestamp":1745914839000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/19325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":84,"alternative-id":["10.7717\/peerj.19325"],"URL":"https:\/\/doi.org\/10.7717\/peerj.19325","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"article-number":"e19325"}}